Rodolfo Proietti
Catholic University of the Sacred Heart
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Rodolfo Proietti.
Anesthesia & Analgesia | 2005
Andrea Casati; Guido Fanelli; Paolo Pietropaoli; Rodolfo Proietti; Rosalba Tufano; Giorgio Danelli; G. Fierro; Germano De Cosmo; Giovanni Servillo
Elderly patients are more prone than younger patients to develop cerebral desaturation because of the reduced physiologic reserve that accompanies aging. To evaluate whether monitoring cerebral oxygen saturation (rSO2) minimizes intraoperative cerebral desaturation, we prospectively monitored rSO2 in 122 elderly patients undergoing major abdominal surgery with general anesthesia. Patients were randomly allocated to an intervention group (the monitor was visible and rSO2 was maintained at ≥75% of preinduction values; n = 56) or a control group (the monitor was blinded and anesthesia was managed routinely; n = 66). Cerebral desaturation (rSO2 reduction <75% of baseline) was observed in 11 patients of the treatment group (20%) and 15 patients of the control group (23%) (P = 0.82). Mean (95% confidence intervals) values of mean rSO2 were higher (66% [64%–68%]) and the area under the curve below 75% of baseline (AUCrSO22< 75% of baseline) was lower (0.4 min% [0.1–0.8 min%]) in patients of the treatment group than in patients of the control group (61% [59%–63%] and 80 min% [2–144 min%], respectively; P = 0.002 and P = 0.017). When considering only patients developing intraoperative cerebral desaturation, a lower Mini Mental State Elimination (MMSE) score was observed at the seventh postoperative day in the control group (26 [25–30]) than in the treatment group (28 [26–30]) (P = 0.02), with a significant correlation between the AUCrSO2 < 75% of baseline and postoperative decrease in MMSE score from preoperative values (r2= 0.25, P = 0.01). Patients of the control group with intraoperative cerebral desaturation also experienced a longer time to postanesthesia care unit (PACU) discharge (47 min [13–56 min]) and longer hospital stay (24 days [7–53] days) compared with patients of the treatment group (25 min [15–35 min] and 10 days [7–23 days], respectively; P = 0.01 and P = 0.007). Using rSO2 monitoring to manage anesthesia in elderly patients undergoing major abdominal surgery reduces the potential exposure of the brain to hypoxia; this might be associated with decreased effects on cognitive function and shorter PACU and hospital stay.
Critical Care Medicine | 2002
Massimo Antonelli; Giorgio Conti; Paolo Pelosi; Cesare Gregoretti; Mariano Alberto Pennisi; Roberta Costa; Paolo Severgnini; Maurizio Chiaranda; Rodolfo Proietti
OBJECTIVE To assess the efficacy of noninvasive pressure support ventilation (NPSV) using a new special helmet as first-line intervention to treat patients with hypoxemic acute respiratory failure (ARF), in comparison to NPSV using standard facial mask. DESIGN AND SETTING Prospective clinical pilot investigation with matched control group in three intensive care units of university hospitals. PATIENTS AND METHODS Thirty-three consecutive patients without chronic obstructive pulmonary disease and with hypoxemic ARF (defined as severe dyspnea at rest, respiratory rate >30 breaths/min, PaO2:FiO2 < 200, and active contraction of the accessory muscles of respiration) were enrolled. Each patient treated with NPSV by helmet was matched with two controls with ARF treated with NPSV via a facial mask, selected by simplified acute physiologic score II, age, PaO2/FiO2, and arterial pH at admission. Primary end points were the improvement of gas exchanges, the need for endotracheal intubation, and the complications related to NPSV. RESULTS The 33 patients and the 66 controls had similar characteristics at baseline. Both groups improved oxygenation after NPSV. Eight patients (24%) in the helmet group and 21 patients (32%) in the facial mask group (p = .3) failed NPSV and were intubated. No patients failed NPSV because of intolerance of the technique in the helmet group in comparison with 8 patients (38%) in the mask group (p = .047). Complications related to the technique (skin necrosis, gastric distension, and eye irritation) were fewer in the helmet group compared with the mask group (no patients vs. 14 patients (21%), p = .002). The helmet allowed the continuous application of NPSV for a longer period of time (p = .05). Length of stay in the intensive care unit, intensive care, and hospital mortality were not different. CONCLUSIONS NPSV by helmet successfully treated hypoxemic ARF, with better tolerance and fewer complications than facial mask NPSV.
Anesthesiology | 2004
Massimo Antonelli; Mariano Alberto Pennisi; Paolo Pelosi; Cesare Gregoretti; Vincenzo Squadrone; Monica Rocco; Luca Cecchini; Davide Chiumello; Paolo Severgnini; Rodolfo Proietti; Paolo Navalesi; Giorgio Conti
BackgroundNoninvasive positive pressure ventilation (NPPV) with a facemask (FM) is effective in patients with acute exacerbation of their chronic obstructive pulmonary disease. Whether it is feasible to treat these patients with NPPV delivered by a helmet is not known. MethodsOver a 4-month period, the authors studied 33 chronic obstructive pulmonary disease patients with acute exacerbation who were admitted to four intensive care units and treated with helmet NPPV. The patients were compared with 33 historical controls treated with FM NPPV, matched for simplified acute physiologic score (SAPS II), age, Paco2, pH, and Pao2:fractional inspired oxygen tension. The primary endpoints were the feasibility of the technique, improvement of gas exchange, and need for intubation. ResultsThe baseline characteristics of the two groups were similar. Ten patients in the helmet group and 14 in the FM group (P = 0.22) were intubated. In the helmet group, no patients were unable to tolerate NPPV, whereas five patients required intubation in the FM group (P = 0.047). After 1 h of treatment, both groups had a significant reduction of Paco2 with improvement of pH; Paco2 decreased less in the helmet group (P = 0.01). On discontinuing support, Paco2 was higher (P = 0.002) and pH lower (P = 0.02) in the helmet group than in the control group. One patient in the helmet group, and 12 in the FM group, developed complications related to NPPV (P < 0.001). Length of intensive care unit stay, intensive care unit, and hospital mortality were similar in both groups. ConclusionsHelmet NPPV is feasible and can be used to treat chronic obstructive pulmonary disease patients with acute exacerbation, but it does not improve carbon dioxide elimination as efficiently as does FM NPPV.
Current Drug Targets | 2005
Maria Giuseppina Annetta; Domenico Iemma; Cristiana Garisto; Chiara Tafani; Rodolfo Proietti
Ketamine is a non-competitive antagonist to the phencyclidine site of N-methyl-d-aspartate (NMDA) receptor for glutamate, though its effects are mediated by interaction with many others receptors. It has been introduced in clinical use since 1960s but today it is not largely employed as a general anaesthetic for its undesired psychic effects (emergence reactions) occurring in approximately 12% of patients. In the last decade, there has been a renewed interest in the use of subanaesthetic doses of ketamine for the treatment of acute and chronic pain. In the late 1990s, multiple prospective, randomised, controlled study has shown the efficacy of low dose of ketamine for postoperative pain relief, for analgesia during regional or local anaesthesia, and for opioid-sparing effect. At present, non-definitive conclusion can be drawn. More data are needed to define the possible long term effects and the clinical goal of ketamine use.
European Journal of Anaesthesiology | 2007
Andrea Casati; Guido Fanelli; P. Pietropaoli; Rodolfo Proietti; R. Tufano; S. Montanini
Background and objectives: The aim of this prospective, observational study was to evaluate changes in regional cerebral oxygen saturation (rSO2) and incidence of intraoperative cerebral desaturation in a cohort of elderly patients undergoing major abdominal surgery. Methods: rSO2 was continuously monitored on the left and right sides of the forehead in 60 patients older than 65 yr (35 males and 25 females; ASA II–III; age: 72 ± 5 yr; without pre‐existing cerebral pathology, and baseline Mini Mental State Examination (MMSE) score >23) undergoing sevoflurane anaesthesia for major abdominal, non‐vascular surgery >2 h. Results: Baseline rSO2 was 63 ± 8%; cerebral desaturation (rSO2 decrease <75% of baseline or <80% in case of baseline rSO2 <50%) occurred in 16 patients (26%). The MMSE decreased from 28 ± 1 before surgery to 27 ± 2 on 7th postoperative day (P = 0.05). A decline in cognitive function (decrease in MMSE score ≥ 2 points one week after surgery as compared to baseline value) was observed in six patients without intraoperative cerebral desaturation (13.6%) and six patients who had intraoperative cerebral desaturation (40%) (P = 0.057) (odds ratio: 4.22; CI95%: 1.1–16). Median (range) hospital stay was 14 (5–41) days in patients with an area under the curve of rSO2 <50% (AUCrSO2<50%) >10 min%, and 10 (4–30) days in those with an AUCrSO2<50% <10 min% (P = 0.0005). Conclusions: In a population of healthy elderly patients, undergoing non‐vascular abdominal surgery cerebral desaturation can occur in up to one in every four patients, and the occurrence of cerebral desaturation is associated with a higher incidence of early postoperative cognitive decline and longer hospital stay.
Canadian Journal of Anaesthesia-journal Canadien D Anesthesie | 2002
Franco Cavaliere; Massimo Antonelli; Andrea Arcangeli; Giorgio Conti; Roberta Costa; Mariano Alberto Pennisi; Rodolfo Proietti
PurposeTo study the analgesic and sedative effects of remifentanil in critically-ill patients.MethodsRemifentanil infusion was started at 0.02 μg·kg−1·min−1 in ten mechanically ventilated critically-ill patients, and the infusion rate was increased to 0.05, 0.10, 0.15, 0.20, and 0.25 μg·kg−1·min−1 every 30 min. Basally and 25 min after each increase we measured: the Ramsey sedation score (RSS) and the respiratory response subscore of comfort scale (CSRR); the bispectral index (BIS) before and after lightly touching tracheal mucosa; heart rate and systemic arterial pressure; respiratory variables; plasma epinephrine and norepinephrine levels.ResultsInfusion rates up to 0.05 μg·kg−1·min−1 were effective against agitation and achieved a good degree of adaption to the respirator in all patients (RSS 2 or more and CSRR 3 or less); BIS decreased significantly; respiratory and circulatory variables were unaffected; mean plasma epinephrine levels decreased. At infusion rates higher than 0.05 μg·kg−1·min−1 RSS but not BIS decreased further and patient arousability caused by noxious stimuli was not prevented; respiratory drive suppression occurred at the infusion rates higher than 0.05 μg·kg−1·min−1 in four patients; bradycardia and arterial hypotension was observed in three patients; plasma epinephrine levels decreased significantly, while norepinephrine was unaffected; severe itching was experienced by one patient.ConclusionsLow doses of remifentanil (upto 0.05 μg·kg−1·min−1) can be useful in critically-ill patients in order to achieve calm and sedation. Higher doses can inhibit respiratory drive and require controlled mechanical ventilation.ZusammenfassungObjectifÉtudier les effets analgésiques et sédatifs du rémifentanil chez de grands malades.MéthodeUne perfusion de rémifentanil a été amorcée à 0,02 μg·kg−1·min−1 chez dix grands malades ventilés mécaniquement. La vitesse de perfusion a été augmentée à 0,05, 0,10, 0,15, 0,20 et 0,25 μg·kg−1·min−1 toutes les 30 min. Au début, et 25 min après chaque augmentation, nous avons mesuré : les scores de sédation de Ramsey (SSR) et le score auxiliaire de réponse respiratoire de l’échelle de confort (RREC); l’index bispectral (BIS) avant et après avoir légèrement stimulé la muqueuse trachéale; la fréquence cardiaque et la tension artérielle générale; les variables respiratoires; les niveaux plasmatiques d’adrénaline et de noradrénaline.RésultatsLes vitesses de perfusion allant jusqu’à 0,05 μg·kg−1·min−1 ont été efficaces contre l’agitation et ont permis une bonne adaptation au respirateur chez tous les patients (2 ou moins à SSR et 3 ou moins à RREC); le BIS a diminué de manière significative; les variables respiratoires et circulatoires n’ont pas été affectées; il y a eu une baisse des niveaux plasmatiques d’adrénaline et de noradrénaline. Sous des vitesses de perfusion plus élevées que 0,05 μg·kg−1·min−1, le SSR, mais non le BIS, a baissé davantage et la réaction des patients aux stimuli nuisibles n’a pu être empêchée; la suppression de la commande respiratoire s’est produite avec des perfusion audessus de 0,05 μg·kg−1·min−1 chez quatre patients; on a observé de la bradycardie et de l’hypotension chez trois patients; les niveaux plasmatiques d’adrénaline ont baissé significativement, mais ceux de la noradrénaline n’ont pas changé; un prurit sévère a été noté chez un patient.ConclusionDes doses faibles de rémifentanil (jusqu’à 0,05 μg·kg−1·min−1) peuvent apporter calme et sédation chez de grands malades. Des doses plus élevées peuvent inhiber la commande respiratoire et exiger une ventilation mécanique contrôlée.
European Journal of Anaesthesiology | 2005
V. A. Peduto; S. Baroncini; S. Montanini; Rodolfo Proietti; L. Rosignoli; R. Tufano; Andrea Casati
Background and objective: This prospective, randomized, observer-blinded study compared onset time and duration of epidural anaesthesia produced by with levobupivacaine and ropivacaine for lower limb surgery. Methods: ASA I-III adult patients undergoing elective lower limb procedures were randomized to receive epidural levobupivacaine 0.5% 15 mL (n = 30) or epidural ropivacaine 0.75% 15 mL (n = 35). A blinded observer evaluated onset time and regression of motor and sensory block, and intraoperative needs for fentanyl supplementation (0.1 mg intravenously). Results: With levobupivacaine, onset time was 29 ± 24 min, with ropivacaine it was 25 ± 22 min (P = 0.41). Complete resolution of motor block required 105 ± 63 min with levobupivacaine and 95 ± 48 min with ropivacaine (P = 0.86). The time for regression of sensory block to T12 was 185 ± 77 min with levobupivacaine and 201 ± 75 min with ropivacaine (P = 0.46). Analgesic supplementation was required in one patient receiving levobupivacaine (3.5%) and in two patients receiving ropivacaine (5.7%) (P = 0.99). Conclusions: In adults undergoing lower limb surgery, levobupivacaine 0.5% 15 mL produces an epidural block with the same clinical profile as ropivacaine 0.75% 15 mL.
Journal of Clinical Anesthesia | 2010
Elisabetta Marana; Stefania Colicci; Francesco Meo; Riccardo Marana; Rodolfo Proietti
STUDY OBJECTIVE To compare intraoperative and postoperative neuroendocrine stress responses during total intravenous anesthesia (TIVA) using propofol and remifentanil versus sevoflurane anesthesia, during laparoscopic surgery. DESIGN Prospective, randomized study. SETTING Tertiary-care university hospital. PATIENTS 46 ASA physical status I patients undergoing laparoscopic surgery for benign ovarian cysts. INTERVENTION Patients were randomly allocated to two groups to receive either TIVA (Group A=23) or sevoflurane anesthesia (Group B=23). MEASUREMENTS Perioperative plasma levels of norepinephrine (NE), epinephrine (E), adrenocorticotropic hormone (ACTH), cortisol, growth hormone (GH), prolactin (PRL), and thyroid hormones (TSH, FT3, FT4) were measured. Blood samples were collected preoperatively, 30 minutes after the beginning of surgery, after extubation, and two and 4 hours after the end of surgery (times 0, 1, 2, 3, and 4). MAIN RESULTS In Group A, perioperative levels of NE, E, ACTH, cortisol, and GH compared with preoperative values significantly decreased; in Group B they increased (Groups A vs. B: time 1, P<0.001 for all markers; time 2, P<0.001 for E, ACTH, cortisol, and GH; time 3, P<0.01 for cortisol, NE, and E, and P<0.05 for ACTH and GH). Perioperative PRL levels were significantly enhanced in both groups versus preoperative values. In both groups, TSH levels increased while FT3 levels decreased significantly relative to basal values. In both groups, perioperative FT4 levels significantly increased compared with preoperative values. CONCLUSIONS TIVA inhibited the ACTH-cortisol axis and reduced NE, E, and GH levels, but it enhanced PRL and had a weak effect on thyroid hormone concentrations as compared to sevoflurane anesthesia.
Critical Care Medicine | 1991
Alessandro Barelli; Maria Rosaria Valente; Antonella Clemente; Patrizia Bozza; Rodolfo Proietti; Francesco Della Corte
ObjectivesTo assess the prognostic reliability of multimodality-evoked potentials and to evaluate the diagnostic implications and define the limits of these evoked potentials. SettingAn ICU in a university hospital. DesignProspective clinical study. PatientsSeventy-three severely head-injured patients aged 10 to 75 yrs. MethodsSerial recording of brainstem auditory-evoked potentials and somatosensory-evoked potentials between days 1 and 21 after trauma. Comparison between evoked potential findings and prognosis, along with clinical data. ResultsConsidering the single recordings of both brainstem auditory-evoked potentials and somatosensory-evoked potentials, the accuracy of prognostication in predicting a bad outcome was good only for severely abnormal brainstem auditory-evoked potentials. Serial brainstem auditory-evoked potential recordings and simultaneous recordings of brainstem auditory-evoked potentials and somatosensory-evoked potentials proved to be good prognostic indices in predicting a favorable outcome. Brainstem auditory-evoked potentials correlated well with brainstem reflexes and with pupil asymmetries but did not correlate with Glasgow Coma Scale scores. ConclusionsSerial recording and the use of a multimodality approach provided the best prognostic capabilities. The main diagnostic implications were: a) the possibility of detecting brainstem compression by means of brainstem auditory-evoked potentials before the appearance of pupil abnormalities; b) the usefulness of brainstem auditory-evoked potentials in monitoring brainstem function in patients undergoing high-dose barbiturate therapy.The main limitations of evoked potentials were the occurrence of peripheral acoustic damage, the electromagnetic sources of artifacts in the ICU, and the administration of ototoxic drugs.
European Journal of Anaesthesiology | 2009
Andrea Russo; Elisabetta Marana; Domenico Viviani; Lorenzo Polidori; Stefania Colicci; Marco Mettimano; Rodolfo Proietti; Enrico Di Stasio
Background and objective Several reports concerning the haemodynamic changes during gynaecologic laparoscopy have been published so far, and the effects of head-down tilt and pneumoperitoneum have not been clearly separated. However, its main effect seems to be an increase in systemic vascular resistance. We investigated how the augmented afterload can affect diastolic function. Methods : Our study involved 20 healthy women, classified as having ASA status I: 10 undergoing laparoscopic hysterectomy and 10 undergoing conventional open hysterectomy. Measurements were made in awake patients and after induction of anaesthesia and then repeated after carbon dioxide insufflation and head-down positioning and at the end of surgery. Diastolic function was primarily studied by transthoracic echocardiography. Results We observed that pneumoperitoneum caused a significant reduction in stroke volume, cardiac output and left ventricular end-diastolic volume; the diastolic filling times showed a progressive reduction in the E-velocity (the velocity of early mitral inflow, corresponding to the ventricular passive filling phase, measured by pulsed-wave Doppler), a prolonged deceleration time and an augmented isovolumetric relaxation time. After head-down tilting, stroke volume, cardiac output and left ventricular end-diastolic volume increased in both laparoscopic hysterectomy and conventional open hysterectomy groups. Conclusion We have found that pneumoperitoneum has important effects on left ventricular volumes, causing a drop in left ventricular end-diastolic volume; it also affects diastolic function with a delay in deceleration time and isovolumetric relaxation time without any effects on intracavitary pressures.